CAMPAIGN

10% off Axol Bioscience Solutions for Stem Cell Research


Use code BNQ42026 when placing your order to get the discount.
Valid until 15.12.2026

 

Working with human iPSCs, stem cell differentiation or disease modelling? 

Axol Bioscience provides human induced pluripotent stem cells (iPSCs), iPSC-derived cell models and specialist services to support advanced stem cell research and the development of physiologically relevant human models. 

Explore solutions for: 

  • Human iPSC lines from patient & unaffected donors 
  • Disease-specific & isogenic iPSC models 
  • iPSC reprogramming 
  • Gene-edited iPSC lines 
  • Custom iPSC differentiation & cell model development 

From Human iPSCs to Advanced Cell Models 

Axol Bioscience provides human iPSC lines, iPSC-derived cell models and specialist services to support stem cell research, disease modelling and drug discovery. 

Human iPSC Lines 

Access a broad collection of human iPSC lines from patient and unaffected donors, providing relevant genetic backgrounds for developing physiologically relevant human cell models. 

Disease-Specific & Isogenic iPSC Models 

Patient-derived and gene-edited iPSC lines provide powerful tools for investigating disease-associated phenotypes. Gene editing can also be used to generate isogenic controls, enabling researchers to investigate the effects of specific genetic variants within a controlled genetic background. 

iPSC Reprogramming & Gene Editing 

Axol provides specialist services to generate and modify human iPSC lines, including: 

  • Reprogramming of donor cells into iPSCs 
  • iPSC characterization and quality control 
  • Gene editing 
  • Development of isogenic iPSC lines 

From iPSCs to Your Cell Type of Interest 

Take your research from pluripotent stem cells to differentiated human cell models through custom iPSC differentiation. 

Axol’s capabilities support the development of physiologically relevant iPSC-derived models for disease modelling, drug discovery and translational research. 

Explore Axol Bioscience’s Stem Cell Resources 

  • Physiologically Relevant Human iPSC-Derived Cell Models & Specialist Services 

A comprehensive overview of Axol’s human iPSC portfolio and capabilities, including patient and unaffected donor iPSC lines, reprogramming, gene editing, differentiation and scalable manufacturing. 

iPSC portfolio

  • Reprogramming Human Donor Material into Induced Pluripotent Stem Cells (iPSCs) 

Discover Axol’s quality-driven approach to reprogramming human donor material into iPSCs, including characterization, quality control and manufacturing considerations. 

Manufacturing process

 

Contact us

 

Naghmeh Rajaei, PhD

Product Specialist

+46 (0)8 588 931 22

naghmeh.rajaei@bionordika.se

Naghmeh Rajaei, PhD